5:00 pm REGISTRATION AND COCKTAILS
6:00 pm OPENING REMARKS
Stanton Honig, MD
Professor of Clinical Urology, Director, Men’s Health Program
6:10 pm Peyronie’s Disease: State of the Art Evaluation and Treatment Options
Stanton Honig, MD
6:25 pm Differentiating Clinically Significant vs Clinically Insignificant Prostate Cancer: Role of Biomarkers, MRI Fusion Biopsy and the Future
MRI Fusion
Preston Sprenkle, MD
Associate Professor of Urology
Biomarkers and Future
Michael Leapman, MD
Assistant Professor of Urology
7:05 pm PSA Screening: Has the Tide Turned Towards More Aggressive Screening?
Moderated by Michael Leapman, MD
David Hesse, MD
Assistant Professor of Clinical Urology
Thomas Martin, MD
Assistant Professor of Clinical Urology
7:35 pm Minimally Invasive BPH Treatments: How to Tailor the Treatment to the Patient
Daniel Kellner, MD
Assistant Professor of Clinical Urology
7:45 pm Male Urethral Stricture Disease: Should We Be Performing More Urethroplasties for Cure?
Jaime Cavallo, MD, MPHS
Assistant Professor of Urology
7:55 pm Hypogonadism: How to Treat in the Older Gentleman, Men of Reproductive Age, and Update on New Delivery Systems
Stanton Honig, MD
8:05 pm Closing Remarks, Q&A
8:30 pm CONCLUDE
The Yale School of Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.